Hirosaki University   University Hospital

2010.4 - 2017.3

Hirosaki University   University Hospital   Associate Professor

2010.4 - 2015.9

Hirosaki University   University Hospital

2010.4 - 2013.6

Hokkaido University   Faculty of Pharmaceutical Sciences   Assistant Professor

2007.4 - 2010.3

海外長期出張 米国ジョージア医科大学生化学部門   博士研究員

2005.3 - 2006.3

博士（薬学）取得

2004.9

北海道大学大学院薬学研究科   助手

2003.2 - 2007.3

医薬品相互作用研究会   理事  

2014.7 - 2017.3   

東北地区病院薬剤師会 学術連絡委員会   委員長  

2014.5 - 2017.3   

青森県病院薬剤師会   理事  

2014.5 - 2017.3   

東北トランスレーショナルリサーチ拠点形成ネットワーク   弘前大学実務担当者  

2014.5 - 2017.3   

青森県病院薬剤師会   薬学教育実務実習検討委員会 委員長  

2014.5 - 2016.3   

医薬品相互作用研究会   編集委員  

2013.6 - 2017.3   

国立大学附属病院臨床研究推進会議   弘前大学代表者  

2012.11 - 2017.3   

東北トランスレーショナルリサーチ拠点形成ネットワーク   弘前大学副代表  

2012.10 - 2014.5   

日本病院薬剤師会   地域編集委員  

2012.7 - 2016.6   

日本病院薬剤師会   東北ブロック第一回学術大会 事務局長  

2011.7 - 2011.11   

日本薬学会   年会問題検討委員会 委員  

2009.4 - 2012.3   

日本薬学会   北海道支部幹事  

2009.4 - 2010.3   

北海道薬物作用談話会   第22回大会 事務局長  

2008.4 - 2008.7   

日本医療薬学会   第18回日本医療薬学会年会 事務局  

2007.10 - 2008.9   

北海道TDM研究会   幹事 （研究発表会 事務局長）  

2006.4 - 2010.3   

Molecular cloning of medaka orexin and orexin receptor and decreased spontaneous movement in response to an orexin inhibitor. Reviewed

Niisawa T, Naruta N, Murakami AM, Yonekura M, Hirota K, Itagaki S, Murakami M

71   55 - 64   2020

Decreased cardiac pacemaking and attenuated β-adrenergic response in TRIC-A knockout mice. Reviewed International journal

Manabu Murakami, Yuichi Toyama, Manabu Yonekura, Takayoshi Ohba, Yasushi Matsuzaki, Daisuke Sawamura, Agnieszka M Murakami, Miyuki Nishi, Shirou Itagaki, Hirofumi Tomita, Hiroshi Takeshima

PloS one   15 ( 12 )   e0244254   2020

Establishment of cardiac action potential recording using a membrane potential indicator in the mouse sinoatrial node. Reviewed

Toyama Y, Yonekura M, Arakawa Y, Higuchi S, Tomita H, Murakami AM, Itagaki S, Murakami M

Hirosaki Med J   70   163 - 171   2020

A simple and dual expression plasmid system in prokaryotic (E. coli) and mammalian cells. Reviewed

Murakami M, Ohba T, Murakami A.M, Han C, Yonekura M, Kuwasako K, Itagaki S

Plos One,   14   e0216169   2019.5

入院患者の健康食品・サプリメントと医薬品の相互作用リスクに関する実態調査 Reviewed

金森 未侑, 冨澤 登志子, 板垣 史郎

日本老年薬学会雑誌   2   9 - 18   2019.4

Medaka as a model for ECG analysis and the effect of verapamil Reviewed

Manabu Yonekura, Nami Kondoh, Chong Han, Yuichi Toyama, Takayoshi Ohba, Kyoichi Ono, Shirou Itagaki, Hirofumi Tomita, Manabu Murakami

Journal of Pharmacological Sciences   137 ( 1 )   55 - 60   2018.5

Modified parasympathetic nervous system in Goto-Kakizaki diabetic rats. Reviewed

Han C, Inaba W, Yonekura M, Ogata Y, Ohba T, Kushikata T, Niwa H, Yanagisawa T, Tomita H, Itagaki S, Hirota K, Akai H, Mizukami H, Murakami M

Hirosaki Med. J.,   68 ( 1 )   33 - 43   2017.10

Storage stability of serum formulations containing ofloxacin for autologous serum eardrop therapy Reviewed

N. Hashimoto, K. Togami, K. Encou, H. Onodera, H. Tanimoto, S. Itagaki, S. Chono

PHARMAZIE   72 ( 3 )   139 - 142   2017.3

Effects of halothane anesthesia on electrocardiogram parameters in mice. Reviewed

Nozaki Shuhei, Ogata Yoshiki, Yonekura Manabu, Han Chong, Niwa Hidetoshi, Kushikata Tetsuya, Hirota Kazuyoshi, Matsuzaki Yasushi, Tomita Hirofumi, Imaizumi Tadaatsu, Itagaki Shirou, Sawamura Daisuke, Murakami Manabu

Hirosaki Med. J.   67 ( 2 )   129 - 135   2017.2

Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary absorption of encapsulated insulin compared with co-administered insulin Reviewed

Sumio Chono, Kohei Togami, Shirou Itagaki

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY   43 ( 11 )   1892 - 1898   2017

「感染性心内膜炎薬物治療の手引き」を用いた抗菌薬適正使用への貢献 Reviewed

小笠原 真帆, 太田, 岡村 祐嗣, 津山 博匡, 板垣 史郎, 萱場 広之, 早狩 誠

日本病院薬剤師会雑誌   52 ( 10 )   1287 - 1292   2016.10

Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces Reviewed

Keita Kaneko, Kohei Togami, Eri Yamamoto, Shujun Wang, Kazuhiro Morimoto, Shirou Itagaki, Sumio Chono

DRUG DELIVERY AND TRANSLATIONAL RESEARCH   6 ( 5 )   565 - 571   2016.10

感染防止対策加算連携施設間における抗菌薬使用量サーベイランスの評価 Reviewed

岡村 祐嗣, 倉内 寿孝, 津山 博匡, 板垣 史郎, 萱場 広之, 早狩 誠

日本環境感染学会誌   31 ( 5 )   326 - 334   2016.9

ヒト官能試験による口腔内崩壊錠の服用性の実証

丁野純男, 谷本裕幸, 松井萌, 中村勝貴, 佐藤卓馬, 中川麻奈, 山田恵乃, 金子圭太, 山佳織, 佐藤恵亮, 山下美妃, 丹保好子, 郡修徳, 森本一洋, 板垣史郎, 葛西亮也

臨床と研究   93 ( 5 )   171 - 174   2016.5

膵臓がん組織の抗がん剤反応性を予測するバイオマーカーの探索 Invited

板垣 史郎

医療の広場,   55   13 - 16   2015.4

THE USEFULNESS OF ANTICANCER DRUG SENSITIVITY TEST (HDRA) FOR THE ADJUVANT CHEMOTHERAPY AND PROFILING IN PANCREATIC CANCER TISSUE AFTER HDRA Reviewed

The Hirosaki medical journal   65 ( 2 )   173 - 181   2014.9

ラット肝化学発癌過程におけるCyclophilin Bの発現変化 Reviewed

細井 一広, 照井 一史, 中川 潤一, 下山 律子, 津山 博匡, 板垣 史郎, 土田 成紀, 早狩 誠

弘前医学   164 - 172   2014.9

PROFILING OF RAT BRAIN PEPTIDES TREATED WITH CENTRALLY ACTIVE ACE INHIBITOR Reviewed

The Hirosaki medical journal   65 ( 1 )   95 - 103   2014.3

Rapid Stimulating Effect of the Antiarrhythmic Agent Amiodarone on Absorption of Organic Anion Compounds Reviewed

Masahiro Segawa, Jiro Ogura, Satoru Seki, Shirou Itagaki, Natsuko Takahashi, Masaki Kobayashi, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki

DRUG METABOLISM AND PHARMACOKINETICS   28 ( 3 )   178 - 186   2013.6

アンジオテンシン変換酵素に焦点を当てた認知症患者への食事支援に関する基礎研究 Reviewed

内山 道子, 板垣 史郎, 金澤 佐知子, 細井 一広, 照井 一史, 下山 律子, 早狩 誠

弘前医学   64   41 - 49   2013.5

STUDY ON IMPROVEMENT OF THE ACCURACY AND PRECISION OF PREDICTED PLASMA CONCENTRATION OF VANCOMYCIN IN THE ADMINISTRATION PLANNING SUPPORT FOR CHILDREN Reviewed

The Hirosaki medical journal   64 ( 1 )   58 - 64   2013.5

処方せんチェックシートを用いたlevofloxacinの用法・用量チェックシステムの効果 Reviewed

岡村 祐嗣, 高橋 志織, 小原 信一, 板垣 史郎, 早狩 誠

医薬品相互作用研究   36   1 - 6   2013.5

IDENTIFICATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE LOCAL PRODUCT OF AOMORI PREFECTURE Reviewed

The Hirosaki medical journal   64 ( 1 )   50 - 57   2013.5

Electrophysiological Characterization of the Polyspecific Organic Cation Transporter Plasma Membrane Monoamine Transporter Reviewed

Shiro Itagaki, Vadivel Ganapathy, Horace T. B. Ho, Mingyan Zhou, Ellappan Babu, Joanne Wang

DRUG METABOLISM AND DISPOSITION   40 ( 6 )   1138 - 1143   2012.6

効果発現パターンにより抗がん薬を分類するための基礎的検討 Reviewed

高橋 夏子, 小林 正紀, 板垣 史郎, 平野 剛, 武隈 洋, 菅原 満, 井関 健

薬学雑誌   132 ( 6 )   777 - 783   2012.6

Effects of Acidification and Alkalinization Agent on Statins-induced Muscle Toxicity Reviewed

Masaki Kobayashi, Kazuhiro Hidaka, Ikumi Chisaki, Natsuko Takahashi, Jiro Ogura, Shirou Itagaki, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   132 ( 5 )   609 - 615   2012.5

Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: The role of protein kinase C (PKC) Reviewed

Katsuya Narumi, Masaki Kobayashi, Sho Otake, Ayako Furugen, Natsuko Takahashi, Jiro Ogura, Shirou Itagaki, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki

INTERNATIONAL JOURNAL OF PHARMACEUTICS   428 ( 1-2 )   25 - 32   2012.5

Involvement of Cholesterol Membrane Transporter Niemann-Pick C1-Like 1 in the Intestinal Absorption of Lutein Reviewed

Yuki Sato, Risa Suzuki, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Toshihiro Noda, Satoshi Mizuno, Mitsuru Sugawara, Ken Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   15 ( 2 )   256 - 264   2012

The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion Reviewed

Jiro Ogura, Yusuke Terada, Takashi Tsujimoto, Takahiro Koizumi, Kaori Kuwayama, Hajime Maruyama, Asuka Fujikawa, Atsushi Takaya, Masaki Kobayashi, Shirou Itagaki, Natsuko Takahashi, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   15 ( 5 )   616 - 631   2012

Intestinal Ischemia-Reperfusion Increases Efflux for Uric Acid Via Paracellular Route in the Intestine, but Decreases that Via Transcellular Route Mediated by BCRP Reviewed

Jiro Ogura, Kaori Kuwayama, Atsushi Takaya, Yusuke Terada, Takashi Tsujimoto, Takahiro Koizumi, Hajime Maruyama, Asuka Fujikawa, Natsuko Takahashi, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Hiroaki Yamaguchi, Ken Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   15 ( 2 )   295 - 304   2012

Protective Effect of Soy Isoflavone Genistein on Ischemia-Reperfusion in the Rat Small Intestine Reviewed

Yuki Sato, Shirou Itagaki, Setsu Oikawa, Jiro Ogura, Masaki Kobayashi, Takeshi Hirano, Mitsuru Sugawara, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   34 ( 9 )   1448 - 1454   2011.9

Protective effect of lutein after ischemia-reperfusion in the small intestine Reviewed

Yuki Sato, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Toshihiro Noda, Satoshi Mizuno, Mitsuru Sugawara, Ken Iseki

FOOD CHEMISTRY   127 ( 3 )   893 - 898   2011.8

Regulation mechanism of ABCA1 expression by statins in hepatocytes Reviewed

Masaki Kobayashi, Keisuke Gouda, Ikumi Chisaki, Manami Ochiai, Shirou Itagaki, Ken Iseki

EUROPEAN JOURNAL OF PHARMACOLOGY   662 ( 1-3 )   9 - 14   2011.7

Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein Reviewed

Yuki Sato, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Toshihiro Noda, Satoshi Mizuno, Mitsuru Sugawara, Ken Iseki

BIOPHARMACEUTICS & DRUG DISPOSITION   32 ( 3 )   151 - 158   2011.4

Alteration of P-gp Expression after Intestinal Ischemia-reperfusion Following 16-h Fasting in Rats Reviewed

Jiro Ogura, Asuka Fujikawa, Hajime Maruyama, Masaki Kobayashi, Shirou Itagaki, Ken Iseki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   131 ( 3 )   453 - 462   2011.3

In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid Reviewed

Yuki Sato, Shirou Itagaki, Toshimitsu Kurokawa, Jiro Ogura, Masaki Kobayashi, Takeshi Hirano, Mitsuru Sugawara, Ken Iseki

INTERNATIONAL JOURNAL OF PHARMACEUTICS   403 ( 1-2 )   136 - 138   2011.1

AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle Reviewed

Ayako Furugen, Masaki Kobayashi, Katsuya Narumi, Meguho Watanabe, Sho Otake, Shirou Itagaki, Ken Iseki

LIFE SCIENCES   88 ( 3-4 )   163 - 168   2011.1

有機アニオントランスポータOATP2B1の臨床的有用性 Invited Reviewed

板垣史郎

医薬品相互作用研究   35 ( 1 )   1 - 10   2011

放射線治療に伴う口腔粘膜障害に対する予防・軽減効果が期待される物質の探索 Reviewed

板垣 史郎, 中田 千絵, 平野 剛, 鷹野 瑠美, 笠師 久美子, 菅原 満, 高橋 夏子, 小林 正紀, 井関 健

医療薬学   36 ( 9 )   696 - 702   2010.9

Regulation of Monocarboxylate Transporter 1 in Skeletal Muscle Cells by Intracellular Signaling Pathways Reviewed

Katsuya Narumi, Ayako Furugen, Masaki Kobayashi, Sho Otake, Shirou Itagaki, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   33 ( 9 )   1568 - 1573   2010.9

Grapefruit juice enhance the uptake of coenzyme Q10 in the human intestinal cell-line Caco-2 Reviewed

Shirou Itagaki, Akiko Ochiai, Masaki Kobayashi, Mitsuru Sugawara, Takeshi Hirano, Ken Iseki

FOOD CHEMISTRY   120 ( 2 )   552 - 555   2010.5

Pharmacokinetics of Oral and Intravenous Administration of Digoxin after Intestinal Ischemia-Reperfusion Reviewed

Jiro Ogura, Hajime Maruyama, Masaki Kobayashi, Shirou Itagaki, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   33 ( 5 )   922 - 925   2010.5

In vitro実験系による肺がん化学療法レジメンの抗腫瘍効果の評価 Reviewed

斎藤 由起子, 平野 剛, 沖 洋充, 笠師 久美子, 菅原 満, 小林 正紀, 高橋 夏子, 板垣 史郎, 井関 健

医療薬学   36 ( 4 )   220 - 226   2010.4

Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: A RPE specific phenomenon Reviewed

Sudha Ananth, Lina Zhuang, Elangovan Gopal, Shiro Itagaki, Babu Ellappan, Sylvia B. Smith, Vadivel Ganapathy, Pamela Martin

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   394 ( 1 )   75 - 80   2010.3

Protective effects of quercetin-3-rhamnoglucoside (rutin) on ischemia-reperfusion injury in rat small intestine Reviewed

Shirou Itagaki, Setsu Oikawa, Jiro Ogura, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

FOOD CHEMISTRY   118 ( 2 )   426 - 429   2010.1

In vitro Evaluation of Anticancer Effects of FOLFIRI and mFOLFOX 6 Chemotherapy Regimens and Their Effects on EGFR Expression Reviewed

sei mei, sei mei, sei mei, sei mei, sei mei, sei mei, sei mei

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)   36 ( 12 )   855 - 862   2010

Expression and Role of SNAT3 in the Placenta Reviewed

C. Yoshioka, S. Yasuda, F. Kimura, M. Kobayashi, S. Itagaki, T. Hirano, K. Iseki

PLACENTA   30 ( 12 )   1071 - 1077   2009.12

Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver Reviewed

Ikumi Chisaki, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1788 ( 11 )   2396 - 2403   2009.11

Intestinal Absorption and Secretion Mechanism of Carboxylate Drugs Invited Reviewed

Shirou Itagaki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   129 ( 11 )   1341 - 1349   2009.11

Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver. Reviewed

Chisaki I, Kobayashi M, Itagaki S, Hirano T, Iseki K

Biochimica et biophysica acta   1788 ( 11 )   2396 - 2403   2009.11

Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver. Reviewed

Chisaki I, Kobayashi M, Itagaki S, Hirano T, Iseki K

Biochimica et biophysica acta   1788 ( 11 )   2396 - 2403   2009.11

Transport by SLC5A8 With Subsequent Inhibition of Histone Deacetylase 1 (HDAC1) and HDAC3 Underlies the Antitumor Activity of 3-bromopyruvate Reviewed

Muthusamy Thangaraju, Senthil K. Karunakaran, Shiro Itagaki, Elangovan Gopal, Selvakumar Elangovan, Puttur D. Prasad, Vadivel Ganapathy

CANCER   115 ( 20 )   4655 - 4666   2009.10

Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment Reviewed

Satoru Yasuda, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

MOLECULAR BIOLOGY REPORTS   36 ( 7 )   1889 - 1896   2009.9

Food-Drug Interaction Involving the Ferulic Acid/H plus Transporter Reviewed

Shirou Itagaki, Yoko Kobayashi, Yoshitaka Saito, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

DRUG METABOLISM REVIEWS   41   60 - 60   2009.8

Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells Reviewed

Satoru Seki, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1788 ( 5 )   911 - 917   2009.5

In vitro and in vivo antioxidant properties of ferulic acid: A comparative study with other natural oxidation inhibitors Reviewed

Shirou Itagaki, Toshirnitsu Kurokawa, Chie Nakata, Yoshitaka Saito, Setsu Oikawa, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

FOOD CHEMISTRY   114 ( 2 )   466 - 471   2009.5

Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells. Reviewed International journal

Seki S, Kobayashi M, Itagaki S, Hirano T, Iseki K

Biochimica et biophysica acta   1788 ( 5 )   911 - 917   2009.5

薬物動態因子の発現変動を反映した肝切除患者に対する薬物治療の最適化に関する研究. Invited

板垣 史郎, 井関 健

医療の広場   49   18 - 20   2009.4

Search for Antioxidative Compounds Capable of Preventing Stomatitis Induced by Chemotherapy Reviewed

TAKANO Rumi, HIRANO Takeshi, NAKATA Chie, KASASHI Kumiko, SUGAWARA Mituru, KOBAYASHI Masaki, ITAGAKI Shirou, ISEKI Ken

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)   35 ( 4 )   247 - 253   2009.4

Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer - Discussion Reviewed

Stephen A. McClave, Gail Cresci

JOURNAL OF GASTROINTESTINAL SURGERY   12 ( 10 )   1781 - 1782   2008.10

Placental folate transport during pregnancy Reviewed

Satoru Yasuda, Satoko Hasui, Chiaki Yamamoto, Chihiro Yoshioka, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY   72 ( 9 )   2277 - 2284   2008.9

Interaction of tryptophan derivatives with SLC6A14 (ATB(0,+)) reveals the potential of the transporter as a drug target for cancer chemotherapy Reviewed

Senthil Karunakaran, Nagavedi S. Umapathy, Muthusarny Thangaraju, Takahiro Hatanaka, Shiro Itagaki, David H. Munn, Puttur D. Prasad, Vadivel Ganapathy

BIOCHEMICAL JOURNAL   414 ( 3 )   343 - 355   2008.9

Interaction of coenzyme Q10 with the intestinal drug transporter P-glycoprotein Reviewed

Shirou Itagaki, Akiko Ochiai, Masaki Kobayashi, Mitsuru Sugawara, Takeshi Hiran, Ken Iseki

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY   56 ( 16 )   6923 - 6927   2008.8

Amiodarone increases the accumulation of DEA in a human alveolar epithelium-derived cell line Reviewed

Satoru Seki, Shirou Itagaki, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   31 ( 7 )   1449 - 1452   2008.7

Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion Reviewed

Jiro Ogura, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

LIFE SCIENCES   82 ( 25-26 )   1242 - 1248   2008.6

Post-transcriptional regulation of breast cancer resistance protein after intestinal ischemia-reperfusion Reviewed

Jiro Ogura, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   31 ( 5 )   1032 - 1035   2008.5

Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins Reviewed

Masaki Kobayashi, Ikumi Chisaki, Katsuya Narumi, Kazuhiro Hidaka, Toshiki Kagawa, Shirou Itagaki, Takeshi Hirano, Ken Iseki

LIFE SCIENCES   82 ( 17-18 )   969 - 975   2008.4

The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo Reviewed

Takeshi Hirano, Satoru Yasuda, Yuki Osaka, Masaru Asari, Masaki Kobayashi, Shirou Itagaki, Ken Iseki

INTERNATIONAL JOURNAL OF PHARMACEUTICS   351 ( 1-2 )   113 - 118   2008.3

Sodium-coupled monocarboxylate transporters in normal tissues and in cancer Invited Reviewed

Vadivel Ganapathy, Muthusamy Thangaraju, Elangovan Gopal, Pamela M. Martin, Shiro Itagaki, Seiji Miyauchi, Puttur D. Prasad

AAPS JOURNAL   10 ( 1 )   193 - 199   2008.3

A new method for determination of both thalidomide enantiomers using HPLC systems Reviewed

Kaname Sgmbongi, Masanori Tanaka, Kelsuke Sakurada, Masakl Kobayasfi, Shlrou Itagaki, Takeshi Hirano, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   31 ( 3 )   497 - 500   2008.3

The mechanism of carrier-mediated transport of folates in BeWo cells: The involvement of heme carrier protein 1 in placental folate transport Reviewed

Satoru Yasuda, Satoko Hasui, Masaki Kobayashi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY   72 ( 2 )   329 - 334   2008.2

Functional analysis of phenolsulfonphthalein transport system in Long-Evans Cinnamon rats Reviewed

Shirou Itagaki, Makoto Chiba, Masaki Kobayashi, Mitsuru Sugawara, Michlya Kobayashi, Takeshi Hirano, Ken Iseki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1778 ( 1 )   270 - 275   2008.1

Contribution of multidrug resistance-associated protein 2 to secretory intestinal transport of organic anions Reviewed

Shirou Itagaki, Makoto Chiba, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   31 ( 1 )   146 - 148   2008.1

Functional analysis of phenolsulfonphthalein transport system in Long-Evans Cinnamon rats. Reviewed International journal

Itagaki S, Chiba M, Kobayashi M, Sugawara M, Kobayashi M, Hirano T, Iseki K

Biochimica et biophysica acta   1778 ( 1 )   270 - 275   2008.1

Bicarbonate supplementation as a preventive way in statins-induced muscle damage Reviewed

Masaki Kobayashi, Toshiki Kagawa, Katsuya Narumi, Shirou Itagaki, Takeshi Hirano, Ken Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   11 ( 1 )   1 - 8   2008

Functional characterization of human monocarboxylate transporter 9 (SLC16A9) Reviewed

Masaki Kobayashi, Toshiki Kagawa, Katsuya Narumi, Kazuhiro Hidaka, Shirou Itagaki, Takeshi Hirano, Ken Iseki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   128   47 - 48   2008

Preventive effects of bicarbonate on cerivastatin-induced apoptosis Reviewed

Masaki Kobayashi, Fumie Kaido, Toshiki Kagawa, Shirou Itagaki, Takeshi Hirano, Ken Iseki

INTERNATIONAL JOURNAL OF PHARMACEUTICS   341 ( 1-2 )   181 - 188   2007.8

Effect of medium pH on the cytotoxicity of hydrophilic statins Reviewed

Masaki Kobayashi, Toshiki Kagawa, Rumi Takano, Shirou Itagaki, Takeshi Hirano, Ken Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   10 ( 3 )   332 - 339   2007.5

Functional and molecular analysis of D-serine transport in retinal Muller cells

Y. Dun, B. Mysona, S. Itagaki, A. Martin-Studdard, V. Ganapathy, S. B. Smith

EXPERIMENTAL EYE RESEARCH   84 ( 1 )   191 - 199   2007.1

Improvement in intestinal coenzyme q10 absorption by food intake Reviewed

Akiko Ochiai, Shirou Itagaki, Toshimitsu Kurokawa, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   127 ( 8 )   1251 - 1254   2007

Characterization of hepatobiliary organic anion transporters in Long-Evans Cinnamon rats Reviewed

Makoto Chiba, Shirou Itagaki, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

DRUG METABOLISM AND PHARMACOKINETICS   22 ( 5 )   387 - 390   2007

Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans Cinnamon rats Reviewed

Makoto Chiba, Shirou Itagaki, Masaki Kobayashi, Takeshi Hirano, Ken Iseki

DRUG METABOLISM AND PHARMACOKINETICS   22 ( 6 )   450 - 455   2007

Efflux transport of n-monodesethylamiodarone by the human intestinal cell-line caco-2 cells Reviewed

Emi Kimoto, Satoru Seki, Shirou Itagaki, Maya Matsuura, Masaki Kobayashi, Takeshi Hirano, Yoshikazu Goto, Koji Tadano, Ken Iseki

DRUG METABOLISM AND PHARMACOKINETICS   22 ( 4 )   307 - 312   2007

Antioxidant activity of a novel extract from bamboo grass (AHSS) against ischemia-reperfusion injury in rat small intestine Reviewed

Toshimitsu Kurokawa, Shirou Itagaki, Toshihiko Yamaji, Chie Nakata, Toshihiro Noda, Takeshi Hirano, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   29 ( 11 )   2301 - 2303   2006.11

Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Reviewed

Hirano T, Yasuda S, Osaka Y, Kobayashi M, Itagaki S, Iseki K

Biochimica et biophysica acta   1758 ( 11 )   1743 - 1750   2006.11

Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Reviewed International journal

Hirano T, Yasuda S, Osaka Y, Kobayashi M, Itagaki S, Iseki K

Biochimica et biophysica acta   1758 ( 11 )   1743 - 1750   2006.11

Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells Reviewed

Takeshi Hirano, Satoru Yasuda, Yuki Osaka, Masaki Kobayashi, Shirou Itagaki, Ken Iseki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1758 ( 11 )   1743 - 1750   2006.11

Characterization of the disposition of lutein after i.v. administration to rats Reviewed

Shirou Itagaki, Wakako Ogura, Yuki Sato, Toshihiro Noda, Takeshi Hirano, Satoshi Mizuno, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   29 ( 10 )   2123 - 2125   2006.10

Protective effect of lutein on ischemia-reperfusion injury in rat small intestine Reviewed

Wakako Ogura, Shirou Itagaki, Toshirnitsu Kurokawa, Toshihiro Noda, Takeshi Hirano, Satoshi Mizuno, Ken Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   29 ( 8 )   1764 - 1766   2006.8

Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain Reviewed

PM Martin, E Gopal, S Ananth, L Zhuang, S Itagaki, BM Prasad, SB Smith, PD Prasad, Ganapathy, V

JOURNAL OF NEUROCHEMISTRY   98 ( 1 )   279 - 288   2006.7

Inhibitory effects of statins on human monocarboxylate transporter 4 Reviewed

Masaki Kobayashi, Yukio Otsuka, Shirou Itagaki, Takeshi Hirano, Ken Iseki

INTERNATIONAL JOURNAL OF PHARMACEUTICS   317 ( 1 )   19 - 25   2006.7

Interaction of ibuprofen and other structurally related NSAIDs with the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8) Reviewed

S Itagaki, E Gopal, LN Zhuang, YJ Fei, S Miyauchi, PD Prasad, Ganapathy, V

PHARMACEUTICAL RESEARCH   23 ( 6 )   1209 - 1216   2006.6

Electrophysiological characterization and Modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3) Reviewed

HK Hu, CJ Endres, C Chang, NS Umapathy, EW Lee, YJ Fei, S Itagaki, PW Swaan, Ganapathy, V, JD Unadkat

MOLECULAR PHARMACOLOGY   69 ( 5 )   1542 - 1553   2006.5

Purification by p-aminobenzoic acid (PABA)-affinity chromatography and the functional reconstitution of the nateglinide/H+ cotransport system in the rat intestinal brush-border membrane Reviewed

Y Saito, S Itagaki, S Kubo, M Kobayashi, T Hirano, K Iseki

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   340 ( 3 )   879 - 886   2006.2

Characterization of secretory intestinal transport of the lactone form of CPT-11 Reviewed

Takemoto, I, S Itagaki, M Chiba, T Itoh, T Hirano, K Iseki

CANCER CHEMOTHERAPY AND PHARMACOLOGY   57 ( 1 )   129 - 133   2006.1

Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. Reviewed

S Yasuda, S Itagaki, T Hirano, K Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   9 ( 1 )   133 - 139   2006.1

Transepithelial transport of telmisartan in Caco-2 monolayers Reviewed

Y Goto, S Itagaki, S Umeda, M Kobayashi, T Hirano, K Iseki, K Tadano

BIOLOGICAL & PHARMACEUTICAL BULLETIN   28 ( 12 )   2235 - 2239   2005.12

Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2) Reviewed

Srinivas, SR, E Gopal, L Zhuang, S Itagaki, PM Martin, YJ Fei, Ganapathy, V, PD Prasad

BIOCHEMICAL JOURNAL   392   655 - 664   2005.12

Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation Reviewed

S Yasuda, S Itagaki, T Hirano, K Iseki

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY   69 ( 10 )   1871 - 1876   2005.10

Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane Reviewed

M Kobayashi, Y Saito, S Itagaki, T Hirano, K Iseki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1715 ( 1 )   19 - 24   2005.8

Phenolsulfonphthalein transport by potential-sensitive urate transport system Reviewed

S Itagaki, S Shimamoto, M Sugawara, M Kobayashi, K Miyazaki, T Hirano, K Iseki

EUROPEAN JOURNAL OF PHARMACOLOGY   518 ( 2-3 )   83 - 89   2005.8

Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane. Reviewed International journal

Kobayashi M, Saito Y, Itagaki S, Hirano T, Iseki K

Biochimica et biophysica acta   1715 ( 1 )   19 - 24   2005.8

Transport mechanism for L-lactic acid in human myocytes using human prototypic embryonal rhabdomyosarcoma cell line (RD cells) Reviewed

M Kobayashi, Fujita, I, S Itagaki, T Hirano, K Iseki

BIOLOGICAL & PHARMACEUTICAL BULLETIN   28 ( 7 )   1197 - 1201   2005.7

Substrate specificity of the nateglinide/H+ cotransport system for phenolic acids Reviewed

Y Saito, S Itagaki, Y Otsuka, Y Kobayashi, H Okumura, M Kobayashi, T Hirano, K Iseki

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY   53 ( 15 )   6100 - 6104   2005.7

Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2 Reviewed

T Itoh, S Itagaki, Y Sumi, T Hirano, Takemoto, I, K Iseki

CANCER CHEMOTHERAPY AND PHARMACOLOGY   55 ( 5 )   420 - 424   2005.5

Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue Reviewed

S Itagaki, Y Sumi, S Shimamoto, T Itoh, T Hirano, Takemoto, I, K Iseki

CANCER CHEMOTHERAPY AND PHARMACOLOGY   55 ( 5 )   502 - 506   2005.5

Food-drug interaction between ferulic acid and nateglinide involving the fluorescein/H+ cotransport system Reviewed

S Itagaki, Y Kobayashi, Y Otsuka, S Kubo, M Kobayashi, T Hirano, K Iseki

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY   53 ( 7 )   2499 - 2502   2005.4

Intestinal uptake of nateglinide by an intestinal fluorescein transporter. Reviewed International journal

Itagaki S, Otsuka Y, Kubo S, Okumura H, Saito Y, Kobayashi M, Hirano T, Iseki K

Biochimica et biophysica acta   1668 ( 2 )   190 - 194   2005.3

Intestinal uptake of nateglinide by an intestinal fluorescein transporter Reviewed

S Itagaki, Y Otsuka, S Kubo, H Okumura, Y Saito, M Kobayashi, T Hirano, K Seki

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1668 ( 2 )   190 - 194   2005.3

Intestinal uptake of nateglinide by an intestinal fluorescein transporter. Reviewed

Itagaki S, Otsuka Y, Kubo S, Okumura H, Saito Y, Kobayashi M, Hirano T, Iseki K

Biochimica et biophysica acta   1668 ( 2 )   190 - 194   2005.3

H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine Reviewed

S Itagaki, Y Saito, S Kubo, Y Otsuka, Y Yamamoto, M Kobayashi, T Hirano, K Iseki

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS   312 ( 1 )   77 - 82   2005.1

Characterization of Secretory Intestinal Transport of Phenolsulfonphthalein Reviewed

Shirou Itagaki, Makoto Chiba, Soji Shimamoto, Mitsuru Sugawara, Michiya Kobayashi, Katsumi Miyazaki, Takeshi Hirano, Ken Iseki

Drug Metabolism and Pharmacokinetics   20 ( 1 )   72 - 78   2005

Mechanism of L-lactic acid transport in L6 skeletal muscle cells. Reviewed

Kobayashi M, Itagaki S, Hirano T, Iseki K

Drug metabolism and pharmacokinetics   19 ( 5 )   363 - 368   2004.10

Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats Reviewed

T Itoh, S Itagaki, K Sasaki, T Hirano, Takemoto, I, K Iseki

JOURNAL OF PHARMACY AND PHARMACOLOGY   56 ( 6 )   809 - 812   2004.6

Comparison of urinary excretion of phenosulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: Involvement of primary active organic anion transporter Reviewed

Shirou Itagaki, Soji Shimamoto, Takeshi Hirano, Ken Iseki, Mitsuru Sugawara, Sachiho Nishimura, Michio Fujimoto, Michiya Kobayashi, Katsumi Miyazaki

Journal of Pharmacy and Pharmaceutical Sciences   7 ( 2 )   227 - 234   2004.5

Biliary excretion of irinotecan and its metabolites. Reviewed

T Itoh, Takemoto, I, S Itagaki, K Sasaki, T Hirano, K Iseki

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES   7 ( 1 )   13 - 18   2004.1

Comparison of the Disposition Behavior of Organic anions in an Animal Model for Wilson's Disease (Long-Evans Cinnamon rats) with that in Normal Long-Evans Agouti rats Reviewed

Shirou Itagaki, Mitsuru Sugawara, Michiya Kobayashi, Katsumi Miyazaki, Takeshi Hirano, Ken Iseki

Drug Metabolism and Pharmacokinetics   19 ( 2 )   150 - 154   2004

Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney Reviewed

S Itagaki, M Sugawara, M Kobayashi, S Nishimura, M Fujimoto, K Miyazaki, K Iseki

EUROPEAN JOURNAL OF PHARMACOLOGY   475 ( 1-3 )   85 - 92   2003.8

Mechanism of Active Secretion of Phenolsulfonphthalein in the Liver via Mrp2 (abcc2), an Organic Anion Transporter Reviewed

Shirou Itagaki, Ken Iseki, Mitsuru Sugawara, Michiya Kobayashi, Katsumi Miyazaki

Drug Metabolism and Pharmacokinetics   18 ( 4 )   238 - 244   2003

アニサキス駆虫薬の探索とDDS創製：魚生食文化継承のため先人の研究挫折を超克する

2019 - 2020

日本学術振興会  科学研究費補助金 挑戦的研究（萌芽） 

丁野 純男

脳内酸化ストレス抑制効果の個体レベル画像化解析に基づくコーヒーポリフェノール・クロロゲン酸の認知症予防機序の解明

2019

全日本コーヒー協会  研究助成 

板垣 史郎

病院看護職のメンタルヘルスケアに貢献する光触媒型・病院臭気脱臭装置の開発

2018

ヘルス・サイエンス・センター  研究助成金 

板垣 史郎

病室不快臭の科学分析に基づく入院高齢者の生活環境改善に関する基礎研究

2018

三井住友海上福祉財団  研究助成 

板垣 史郎

ライフスタイルに発症起因する難治性肺疾患の征圧基盤：肺投与型DDSがその扉を開く

2017 - 2020

日本学術振興会  科学研究費補助金 基盤研究B 

丁野 純男

糖尿病患者の健やかな老いを創出・支援する介入的アルツハイマー病併発予防法の開発

2014 - 2017

日本学術振興会  科学研究費補助金 若手研究A 

板垣 史郎

膵臓がん組織の抗がん剤反応性を予測するバイオマーカーの探索

2013

政策医療振興財団  研究助成金 

板垣 史郎

認知症の治療へ向けた脳インスリン応答性ペプチダーゼの記憶制御における役割の解明

2012

医科学応用研究財団  研究助成金 

板垣 史郎

アンジオテンシン変換酵素を標的とした大豆由来内臓脂肪型肥満症改善物質の探索

2012

不二たん白質研究振興財団  若手研究助成 

板垣 史郎

大豆の認知能増強効果の実験的検証とその機構解明

2012

飯島記念食品科学振興財団  学術研究助成金 

板垣 史郎

アンジオテンシンⅡを介した脂肪細胞の分化・増殖機構の解明

2012

唐牛記念医学研究基金  助成金B 

板垣 史郎

食品機能成分による新規大腸癌抑制遺伝子の制御

2011 - 2012

日本学術振興会  科学研究費補助金 挑戦的萌芽研究 

板垣 史郎

脳インスリン応答性ペプチダーゼを介した記憶制御機構の解明

2011

武田科学振興財団  薬学系研究奨励 

板垣 史郎

タマネギの虚血性腸管障害予防作用に関する研究

2010

食生活研究会  研究助成金 

板垣 史郎

肺がん組織に高発現するトランスポータLAT1を標的とした抗がん剤感受性増強戦略

2010

弘前大学  若手研究者支援事業 

板垣 史郎

母集団パラメータ解析に基づく小児バンコマイシン血中濃度の予測精度向上

2010

臨床薬理研究振興財団  研究奨励金 

板垣 史郎

第9回 生体異物研究に関する国際会議

2010

金原一郎記念医学医療振興財団  研究交流助成金 

板垣 史郎

2010年 世界薬学会議/北米薬学会年会 合同会議

2010

薬学研究奨励財団  海外派遣助成 

板垣 史郎

致死的薬剤誘発性肺炎の予防

2010

上原記念生命科学財団  研究奨励金 

板垣 史郎

食品機能成分の体内動態特性に基づく薬剤性肺障害の予防

2009 - 2011

文部科学省  科学研究費補助金 若手研究A 

板垣 史郎

ルテインの化学的特性を利用した薬剤性肺障害予防法の確立

2009

旗影会  研究助成 

板垣 史郎

大豆ポリフェノールの抗酸化作用に基づく虚血・再灌流障害予防法の構築

2009

不二たん白質研究振興財団  若手研究助成 

板垣 史郎

消化管トランスポータOATPを標的とした胆汁酸成分吸収促進技術の開発

2009

持田記念医学薬学振興財団  研究助成 

板垣 史郎

In vitro妊娠進行モデルを活用した、妊婦栄養指導プログラムの策定

2009

花王健康科学協会  研究助成 

板垣 史郎

コーヒーの虚血性腸管障害予防作用に関する研究

2009

すかいらーくフードサイエンス研究所  研究助成 

板垣 史郎

ハスカップを用いたがん治療に伴う重篤な副作用、口内炎の治療法

2008

ノーステック財団基盤的研究開発育成事業  スタートアップ研究補助金 

板垣 史郎

トランスポータ発現変動を反映した小腸虚血再灌流障害患者への適切な薬物投与指針の構築に関する研究

2008

中冨健康科学振興財団  研究助成 

板垣 史郎

In vitro肺胞上皮モデルを用いた薬物肺移行メカニズムの解析

2008

北海道大学重点配分経費  若手研究者自立支援 

板垣 史郎

食生活に応じた適切なOTC薬選択基準の確立に向けた薬物動態学的研究

2008

一般用医薬品セルフメディケーション振興財団  調査研究助成 

板垣 史郎

薬物動態因子の発現変動を反映した肝切除患者に対する薬物治療の最適化に関する研究

2008

政策医療振興財団  研究助成 

板垣 史郎

国際薬物動態学会 第15回北米年会

2008

伊藤医薬学術交流財団  海外交流助成 

板垣 史郎

ダッタンそばの機能性成分であるルチンに着目した酸化ストレス性疾患の予防に関する多面的研究

2008

東和食品研究振興会  研究助成 

板垣 史郎

抗がん剤の重篤な副作用である口内炎に対する豆類ポリフェノールの治療効果

2008

タカノ農芸化学研究助成財団  若手研究助成 

板垣 史郎

天然食用色素ルテインの生理的有用性に関する多角的検証

2008

旗影会  研究助成 

板垣 史郎

日本人に高頻度に発現する薬剤性肺障害の予防に関する研究

2008

薬学研究奨励財団  研究助成 

板垣 史郎

日本人に高頻度に発現する薬剤性肺障害の予防

2007

北海道大学重点配分経費  若手研究者の研究支援 

板垣 史郎

小腸虚血再灌流による多臓器トランスポータ発現変動機構の解明

2007

ノーステック財団  基盤的研究開発育成事業（若手研究補助金） 

板垣 史郎

第３回世界薬学会議

2007

加藤記念バイオサイエンス研究振興財団  加藤記念国際交流助成 

板垣 史郎

トランスポータ発現変動を反映した肝切除・肝移植患者への適切な薬物投与指針の構築に関する研究

2007

栗林育英学術財団  研究助成 

板垣 史郎

機能性食品の開発に貢献する新しい吸収改善理論の確立と新規配合剤の開発

2007

浦上食品・食文化振興財団  研究助成金 

板垣 史郎

腎有機アニオントランスポータ欠損モデルラットの確立

2005 - 2006

文部科学省  科学研究費補助金 若手研究B 

板垣 史郎, 内定後辞退

塩酸イリノテカンの副作用回避のための基礎的研究：消化管透過機構からのアプローチ

2004

秋山記念生命科学振興財団  奨励研究助成 

板垣 史郎

腎有機アニオントランスポータ欠損モデル動物の確立

2004

ノーステック財団  基盤的研究開発育成事業（若手研究補助金） 

板垣 史郎

Prevention of adverse-effects of drugs

OSCE対応演習

臨床薬理学

チュートリアル授業

PBL教育

薬理学実習

薬学実務実習

薬理学

臨床薬理学